SOM Biotech announces the election of Silvia Panigone as Executive Chair

posted on March 27, 2024

Barcelona, Spain, March 26th, 2024. SOM Biotech (SOM), a clinical-stage drug discovery and development company based on a unique and proprietary Artificial Intelligent (AI) platform, appoints Silvia Panigone PhD, MBA as Executive Chair of the Board of SOM.

Press Release: SOM Biotech announces the election of Silvia Panigone as Executive Chair